Puritan Medical Products, Thermo Fisher Scientific Inc. and BD are Dominating in the North America Swabs Collection Kits Market in 2020

The Swabs Collection Kits Market is expected to grow with the CAGR of 5.1% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/north-america-swabs-collection-kits-market

North America Swabs Collection Kits Market is a highly consolidated market which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.    

The major players dealing in North America swabs collection kits market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition and agreement into the market. This has helped companies to maximize the sales with enhanced product portfolio. For instance, in August 2020, GeneDx, Inc. announced the launch of GenomeXpress, a rapid genome sequencing test. The test is used to identify variations in any part of the gene. With this new launch, the company is likely to grow in coming years.

Puritan Medical Products is the dominating player in the North America swabs collection kits market. The other players included in the swabs collection kits market are Quidel Corporation, DiaSorin Molecular LLC, Medline Industries, Inc., Starplex Scientific Inc., GeneDx, Inc., BD, COPAN Diagnostics Inc., BTNX Inc., Norgen Biotek Corp., Thermo Fisher Scientific Inc., Hologic, Inc., Path-Tec, LLC, Quest Diagnostics Incorporated, Hardy Diagnostics among others.

 North America Swabs Collection Kits MarketPuritan Medical Products:

Puritan Medical Products is headquartered in Maine, U.S. and was founded in 1919. The company is engaged in the manufacturing of swabs kit among other products to deliver innovative solutions for even the most demanding applications. The company is providing products under categories such as controlled environments, diagnostics/specimen collection, environmental, forensics/genetics, microbiology media and medical among which controlled environments, diagnostics/specimen collection, forensics/genetics and medical are the market focused categories.

For instance,

  • In January 2021, Puritan Medical Products announced that it has been awarded USD 110.00 million by Department of Health and Human Services in collaboration with Department of Defence to procure production equipment necessary to increase domestic production capability of foam tip swabs for COVID-19 diagnostic tests. This will help the company to expand its market in coming years.

The company has wide presence across North America, South America, Europe, Middle East and Africa and Asia-Pacific.

Thermo Fisher Scientific Inc.:

Thermo Fisher Scientific Inc. is headquartered in Massachusetts, U.S. and was founded in 2006. The company is focused on making the world healthier, cleaner and safer by accelerating life science research, solving complex analytical challenges and improving patients’ therapies and diagnostics. The company deals in multiple business segments namely life science solutions, analytical instruments, specialty diagnostics and laboratory products and services among which specialty diagnostics is the market focused segment. The company is providing products under categories such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon out of which Thermo Scientific is the market focused category. The company is engaged in continuous development of swabs collection kits and related products.    

For instance,

  • In October 2020, Thermo Fisher Scientific Inc. announced the expansion of its COVID-19 testing along with sample collection kits by Everlywell. The company received Emergency Use Authorisation (EUA) for the product TaqPath COVID-19 Combo Kit which also includes additional method for sample collection which is provided by Everlywell. This has enabled individual customers to collect samples using the nasal swab samples when determined by their healthcare practitioners. This will help in the growth of the market in the coming years.

The company has wide presence across Europe, North America and Asia-Pacific. The company has various subsidiaries such as Thermo Electron North America LLC (U.S.), Fisher Scientific GmbH (Germany), Fisher Scientific Korea Ltd (Korea), Thermo Fisher Scientific Germany BV & Co KG (Germany), Thermo Fisher Scientific K.K. (Japan) among others.

BD:

BD is headquartered in New Jersey, U.S. and was founded in 1897. The company is engaged in the development, manufacture and sale of broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions which also provide customer solutions that are focused on improving medication management and patient safety among others. The company deal in multiple business segments namely BD medical, BD life science and BD interventional among which BD life science is the market focused segment. The company is providing products under categories such as anaesthesia delivery, biopsy, biosciences, biosurgery, cervical cancer screening, diabetes care, drainage, drug delivery system, gastrointestinal care, hazardous drug safety, hernia repair and fixation, homecare, infection prevention, infusion therapy, interventional specialities, lab automation, medication and supply management, microbiology solution, molecular diagnostic, patient monitoring, prostrate health, respiratory care, sharp disposal solution, software solution, specimen collection, surgical instruments, syringes and needles, urology and kidney health, vascular access, vascular surgery and wound care out of which specimen collection is the market focused category.

For instance,

  • In November 2020, BD announced that their rapid point-of-care antigen tests have been authorized for use by Health Canada under the Interim Order. These tests provide benefit of sample collection through a mid-nasal swab which has been said to be less invasive than the nasopharyngeal swabs. The ease of use and surge in demand has proved to be helpful for the growth of the market and may continue to grow in coming years.

The company has wide presence across North America, South America, Europe, Middle East and Africa and Asia-Pacific. The company has various subsidiaries such as Care Fusion (U.S.), C.R. Bard (U.S.), Accuri Cytometers Inc. (U.S.), Becton Dickson UK ltd. (U.K.) and Straub medical AG (Switzerland) among others.